Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114


[Feasibility of assessing EGFR mutation and others using samples obtained by EBUS transbronchial needle aspiration].

Boulanger S, Delattre C, Descarpentries C, Escande F, Bouchindhomme B, Copin MC, Dhalluin X, Scherpereel A, Ramon PP, Cortot A, Fournier C.

Rev Mal Respir. 2013 May;30(5):351-6. doi: 10.1016/j.rmr.2012.12.013. Epub 2013 Jan 23. French.


Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed?

Yarmus L, Akulian J, Gilbert C, Feller-Kopman D, Lee HJ, Zarogoulidis P, Lechtzin N, Ali SZ, Sathiyamoorthy V.

Ann Am Thorac Soc. 2013 Dec;10(6):636-43. doi: 10.1513/AnnalsATS.201305-130OC.


Pyrosequencing analysis of EGFR and KRAS mutations in EUS and EBUS-derived cytologic samples of adenocarcinomas of the lung.

Stigt JA, 'tHart NA, Knol AJ, Uil SM, Groen HJ.

J Thorac Oncol. 2013 Aug;8(8):1012-8. doi: 10.1097/JTO.0b013e31829ce93e.


Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.

Santis G, Angell R, Nickless G, Quinn A, Herbert A, Cane P, Spicer J, Breen R, McLean E, Tobal K.

PLoS One. 2011;6(9):e25191. doi: 10.1371/journal.pone.0025191. Epub 2011 Sep 19.


Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.

Esterbrook G, Anathhanam S, Plant PK.

Lung Cancer. 2013 Apr;80(1):30-4. doi: 10.1016/j.lungcan.2012.12.017. Epub 2013 Jan 10.


EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.

Billah S, Stewart J, Staerkel G, Chen S, Gong Y, Guo M.

Cancer Cytopathol. 2011 Apr 25;119(2):111-7. doi: 10.1002/cncy.20151. Epub 2011 Mar 11.


[Is it possible to use molecular biology techniques on endobronchial ultrasound-guided transbronchial needle aspirations (EBUS-PTBA)? A challenge].

Gounant V, Fleury-Feith J, Wislez M.

Rev Mal Respir. 2013 May;30(5):345-7. doi: 10.1016/j.rmr.2013.05.004. French. No abstract available.


Randomized Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration With and Without Rapid On-site Evaluation for Lung Cancer Genotyping.

Trisolini R, Cancellieri A, Tinelli C, de Biase D, Valentini I, Casadei G, Paioli D, Ferrari F, Gordini G, Patelli M, Tallini G.

Chest. 2015 Dec;148(6):1430-1437. doi: 10.1378/chest.15-0583.


Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer.

Folch E, Yamaguchi N, VanderLaan PA, Kocher ON, Boucher DH, Goldstein MA, Huberman MS, Kent MS, Gangadharan SP, Costa DB, Majid A.

J Thorac Oncol. 2013 Nov;8(11):1438-1444. doi: 10.1097/JTO.0b013e3182a471a9.


EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods.

Schmid-Bindert G, Wang Y, Jiang H, Sun H, Henzler T, Wang H, Pilz LR, Ren S, Zhou C.

PLoS One. 2013 Oct 29;8(10):e77948. doi: 10.1371/journal.pone.0077948. eCollection 2013.


Triple Gene Analysis Using Samples Obtained by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration.

Lee K, Um SW, Jeong BH, Yang JW, Choi YL, Han J, Kim H, Kwon OJ.

Intern Med. 2016;55(21):3105-3111. Epub 2016 Nov 1.


Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

van Eijk R, Licht J, Schrumpf M, Talebian Yazdi M, Ruano D, Forte GI, Nederlof PM, Veselic M, Rabe KF, Annema JT, Smit V, Morreau H, van Wezel T.

PLoS One. 2011 Mar 8;6(3):e17791. doi: 10.1371/journal.pone.0017791.


Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.

Casadio C, Guarize J, Donghi S, Di Tonno C, Fumagalli C, Vacirca D, Dell'Orto P, De Marinis F, Spaggiari L, Viale G, Barberis M.

Am J Clin Pathol. 2015 Oct;144(4):629-34. doi: 10.1309/AJCPXGRAIMB4CTQ3.


Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients.

Lewandowska MA, Jóźwicki W, Jochymski C, Kowalewski J.

Oncol Rep. 2013 Sep;30(3):1045-52. doi: 10.3892/or.2013.2579. Epub 2013 Jul 1.


Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS.

Guisier F, Salaün M, Lachkar S, Lamy A, Piton N, Obstoy B, Sabourin JC, Thiberville L.

Respirology. 2016 May;21(4):718-26. doi: 10.1111/resp.12737. Epub 2016 Jan 27.


Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.

Rekhtman N, Brandt SM, Sigel CS, Friedlander MA, Riely GJ, Travis WD, Zakowski MF, Moreira AL.

J Thorac Oncol. 2011 Mar;6(3):451-8. doi: 10.1097/JTO.0b013e31820517a3.


Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients.

Ulivi P, Romagnoli M, Chiadini E, Casoni GL, Capelli L, Gurioli C, Zoli W, Saragoni L, Dubini A, Tesei A, Amadori D, Poletti V.

Int J Oncol. 2012 Jul;41(1):147-52. doi: 10.3892/ijo.2012.1432. Epub 2012 Apr 10.


EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).

Reynolds JP, Tubbs RR, Minca EC, MacNamara S, Almeida FA, Ma PC, Pennell NA, Cicenia JC.

Lung Cancer. 2014 Nov;86(2):158-63. doi: 10.1016/j.lungcan.2014.09.003. Epub 2014 Sep 22.


Supplemental Content

Support Center